Top

Pathology & Oncology Research

Published in:

01-12-2006 | Article

Periacinar clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma

Authors: Bozo Krušlin, MD, PhD, Davor Tomas, Aida Čviko, Hrvoje Čupić, Ljubica Odak, Mladen Belicza

Published in: Pathology & Oncology Research | Issue 4/2006

Title: Periacinar clefting and p63 immunostaining in prostatic intraepithelial neoplasia and prostatic carcinoma
Authors: Bozo Krušlin, MD, PhD
Davor Tomas
Aida Čviko
Hrvoje Čupić
Ljubica Odak
Mladen Belicza
Publication date: 01-12-2006
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2006
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02893413

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2006

Human papilloma virus and p53 expression in bladder cancer in Egypt: Relationship to schistosomiasis and clinicopathological factors

Asymmetric calf hypertrophy of neurogenic origin

Malignant pilomatricoma in the parietal area

Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx™ in paraffin-embedded cancer tissues

Significance of oral Candida infections in children with cancer

Lithium suppresses epidermal SERCA2 and PMR1 levels in the rat

Keynote webinar | Spotlight on antibody–drug conjugates in cancer